Melody International Ltd.

Founded in 2015 and based in Kagawa, Japan, Melody International Ltd. specializes in perinatal telemedicine solutions, enhancing maternal and neonatal health management through innovative technology and remote monitoring services. Melody International Ltd. provides a telemedicine platform that focuses on maternal and neonatal health.

The company was founded in 2015 in Kagawa, Japan. Yhuko Ogata serves as the CEO. In November 2023, the company raised JPY 110 million in venture funding from investors including Tokai Tokyo Investment and Kyoto University Innovation Capital, bringing the total amount raised to JPY 110 million across four deals. Melody International Ltd.

specializes in a perinatal telemedicine platform known as 'Melody i,' aimed at enhancing maternal and neonatal health management through information and communication technology (ICT). This platform features a mobile fetal monitoring device that integrates a fetal heart rate monitor with a labor contraction monitor, allowing healthcare providers to remotely assess the health conditions of mothers and their babies. The primary use case facilitates real-time communication between pregnant women and healthcare professionals, ensuring timely health assessments and support crucial for safe deliveries. The service primarily targets hospitals, maternal health clinics, and healthcare providers in Japan, with plans for expansion into other regions.

Melody International Ltd. generates revenue through a subscription model for healthcare providers using the 'Melody i' platform. Hospitals and clinics subscribe for ongoing access to the services, with potential fees based on the number of users or consultations. Additionally, the company may earn revenue from the direct sale of its mobile monitoring devices to healthcare providers, utilizing a B2B approach to establish steady revenue streams through contractual agreements.

In November 2023, Melody International Ltd. secured JPY 110 million in funding to advance the introduction of new equipment and systems both domestically and internationally. The company aims to enhance its product offerings while exploring expansion into new markets, particularly targeting regions where telemedicine is gaining momentum. Specific upcoming products and their release dates have not been disclosed, but the funding will support their ongoing efforts to improve maternal health services.